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Introduction: Nuclear grading involves an evaluation of the size 
and shape of nuclei and the percentage of tumor cells that are in the 
mitotic phase. To estimate the degree of aggressiveness, this approach 
has been applied to various types of carcinomas, such as breast carci-
noma and pulmonary adenocarcinoma (Nakazato et al.). In the pres-
ent study, we estimated and evaluated the interobserver variability of 
nuclear grading in primary pulmonary adenocarcinomas.
Methods: We selected 122 primary pulmonary adenocarcinomas 
measuring 2 cm or less in diameter. Eight pathologists indepen-
dently evaluated the nuclear factors, using the nuclear grading sys-
tem reported previously by Nakazato et al. The same pathologists 
also used both the international multidisciplinary classification of 
pulmonary adenocarcinoma (2011 International Association for the 
Study of Lung Cancer classification) and Noguchi’s classification, 
and assessed the extent of the lepidic pattern in the largest cut surface 
of the tumor. Interobserver agreement was evaluated using the κ sta-
tistic. The disease-free survival curves of the patients were obtained 
using the Kaplan–Meier method and analyzed with the log-rank test.
Results: The mean (±SD) κ values for the two histological classifi-
cations, the extent of the lepidic pattern, and nuclear grading were 
0.46 ± 0.09, 0.48 ± 0.09, 0.45 ± 0.16, and 0.58 ± 0.09, respectively. 
The cases judged as negative on the basis of nuclear grading showed 
a significantly better prognosis (5-year disease-free survival rate; 
91.8% ± 2.7) than the positive cases did (68.6% ± 3.1).
Conclusion: Nuclear grading is practical for prognostic evaluation 
of pulmonary adenocarcinoma. The interobserver agreement for 
nuclear grading is significantly higher than for histological classi-
fications and the extent of the lepidic pattern. Nuclear grading is a 
reliable prognostic indicator for small adenocarcinomas.
Key Words: Nuclear grading, Pulmonary adenocarcinoma, 
Interobserver agreement, Histological classification, Extent of lep-
idic area.
(J Thorac Oncol. 2013;8: 736-743)
The histological grading of lung cancer is a significant indicator of prognosis.1 Many prognostic factors of pul-
monary carcinoma have been shown to correlate with patient 
outcome.1 Among them, histopathological subtype, epidermal 
growth factor receptor expression, and degree of tumor dif-
ferentiation have been reported to be useful for estimation 
of cancer malignancy.2 Although most studies have shown 
that tumor grading is associated with patient survival, it has 
been questioned whether it can be applied practically or has 
clinicopathological significance.3 Furthermore, methods for 
assessing tumor grade vary and are usually a composite of 
different parameters including histopathological subtype, the 
proportion of the lepidic lesion, and nuclear size.3,4 Although 
these parameters yield prognostic information, their relative 
importance remains uncertain. As all these parameters involve 
subjective assessment, interobserver variability should be suf-
ficiently tested before they can be used on a practical basis.
Davis et al.5 found a significant association between the 
tumor grade of breast cancer and prognosis, as determined 
by a central review panel and pathologists at a local clinic, 
despite the fact that precise agreement between the panel and 
the pathologists was achieved in only 54% of cases. Henson6 
noted that the most appropriate endpoint for testing the value 
and validity of tumor grading is patient outcome. He considers 
that variation in grading among individual pathologists may 
not significantly interfere with the estimation of prognosis 
in cancer patients. However, agreement of interobserver 
diagnosis or judgment should be suppressed as far as possible.
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Our previous study of the relationship between nuclear 
grade and prognosis revealed a strong correlation, even 
when data were collected from more than one pathologist.4 
Taking interobserver agreement into consideration, we inves-
tigated interobserver variability of the nuclear grading system 
reported previously. The present study examined the useful-
ness of nuclear grading in comparison with the international 
multidisciplinary classification of pulmonary adenocarci-
noma,7 Noguchi’s classification,8 and the extent of the lepidic 
pattern in the largest cut surface of the tumor.9,10
PATIENTS AND METHODS
Patients
Primary tumors were obtained from 275 patients with 
pulmonary adenocarcinomas 2 cm or lesser in maximum 
diameter, who had been treated surgically between January 
2001 and December 2003 at the National Cancer Center 
Hospital, Tokyo. From this series of 275 patients, 95 who 
were alive without tumor were randomly selected. In addition, 
27 patients who had a relapse were also selected. A total of 
122 (95 + 27) patients were selected for this study. A scheme 
of the study population is shown in Supplemental Figure 1 
(Supplemental Digital Content 1, http://links.lww.com/JTO/
A405). One hundred three patients underwent standard surgi-
cal resection of their tumors along with mediastinal and pul-
monary hilar lymph node dissection. Five patients underwent 
segmentectomy of their tumors along with pulmonary hilar 
lymph node dissection. Fourteen patients underwent partial 
resection of their tumors along with a sampling lymph node 
dissection. Informed consent for specimen collection was 
obtained from all patients. None of the patients selected had 
received neoadjuvant chemotherapy or radiotherapy before 
surgery.
Tissue Specimens and Pathologic Information
The resected specimens were fixed with 10% to 15% 
neutral buffered formalin at room temperature and then 
embedded in paraffin for histologic examination. As the 
tumors were 2 cm or less in maximum diameter, we were able 
to make one paraffin block per tumor. The cut surface of each 
tumor was stained with hematoxylin and eosin and examined 
by light microscopy. Tumors were classified according to the 
criteria of the international multidisciplinary classification4 
of lung adenocarcinoma (2011 International Association for 
the Study of Lung Cancer [IASLC] classification) and the 
histological criteria proposed by Noguchi et al.5 (Noguchi’s 
classification). In terms of the extent of the lepidic pattern, we 
used 75% as cutoff rates. In the previous studies by Yokose 
et al.,11 Anami et al.,10 and Yoshizawa et al.2 75%, 50%, and 
predominancy of lepidic growth area (2011 IASLC classifi-
cation) were used as cutoff rates to compare the prognosis. 
In the present study, we chose the strictest criteria to repre-
sent the extent of the lepidic growth pattern. Diagnoses were 
performed by eight pathologists (MN, YI, AM, JF, YT, TY, 
YY, and YN) using a BX50 or BX51 microscope (Olympus, 
Tokyo, Japan). To avoid any errors through use of different 
models of microscope, two participants (YN and MN) using 
BX50 and BX51 microscopes confirmed that their results 
were similar. However, it is always necessary to be mindful 
of potential errors when applying such criteria practically in 
routine examinations. To decrease such measurement bias, 
we used a blind test method. Cancer staging of specimens 
was determined in accordance with the International Union 
against Cancer tumor, node, metastasis classification of 
malignant tumors, 7th edition.
Nuclear Grading Criteria
We formerly reported that the nuclear grading system to 
be a useful parameter for prognostication of small pulmonary 
adenocarcinomas.3 In the present trial, we attempted to apply 
nuclear grading to routine histological diagnosis. As a standard 
for nuclear size, we used small lymphocytes. The mean (±SD) 
values of the nuclear area (NA) and nuclear dimension (ND) 
of small lymphocytes were NA 14 μm2 (± 4 SD) and ND 3.9 
μm (± 0.03 SD), respectively. Therefore, the NA of 67 μm2, 
which was indicated to be the critical size in the former study 
was approximately five times larger than that of lymphocytes, 
and the ND level of 10.7 μm, which was also indicated pre-
viously to be the critical size was approximately three times 
larger. We chose fields where the large nuclei were frequently 
observed from the largest cut surface of each tumor. Necrotic 
and inflammatory areas were avoided, and overlapping nuclei 
were omitted. Any tumor cell was judged to be positive, if its 
NA and ND were five and three times larger, respectively, than 
the corresponding values of small lymphocytes.
The participants reviewed each slide in detail, using low 
magnification (×40) and selected a few areas that included 
tumor cells with large nuclei. The number of tumor cells 
judged to be positive was then counted, and a field was judged 
as positive field if it contained more than five positive cells. 
The case was judged as a positive case if more than three such 
positive fields were observed.
FIGURE 1.  Histology of a small pulmonary adenocarcinoma 
judged to be lepidic-pattern predominant on the basis of the 
international multidisciplinary classification (8 of 8 patholo-
gists), type B by Noguchi’s classification (4 of 8 pathologists), 
and negative by the nuclear grading system (8 of 8 patholo-
gists). Hematoxylin and eosin stain, original magnifications 
×400 and ×40.
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Statistical Analysis
Analysis of the correlation between the number of 
subtypes and the diagnosis made by the pathologists was 
performed using the F test. Interobserver variability was 
evaluated using the κ statistic. The κ statistic value was used 
not only for nuclear grading, but also for the 2011 IASLC 
classification and Noguchi’s classification. The degree of 
agreement in terms of the κ statistic was as follows: κ value = 
0.00, poor agreement; 0.00 to 0.20, slight agreement; 0.21 to 
0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 
to 0.80, substantial agreement; 0.81 to 1.00, almost perfect 
agreement.13
The disease-free survival curve was obtained using the 
Kaplan–Meier method. Disease-free survival was calculated 
from the date of primary surgery for lung tumors, to the date 
of relapse or last follow-up. The curves were evaluated by the 
log-rank test. Data were censored when patients were lost to 
follow-up. All analyses were performed using the SPSS 12.0 
software package (SPSS Inc., Chicago, IL).
RESULTS
Clinical Findings
The clinicopathologic features of the cases examined are 
listed in Table 1. Follow-up was completed for all patients up 
to January 2008 and ranged from 2 to 91 months (mean: 55.3; 
median: 61). The 5-year disease-free survival rates for stages 
I, II, and III were 90.6%, 33.3%, and 28.6%, respectively.
Interobserver Variability
Eight pulmonary pathologists (MN, YI, AM, JF, YT, 
TY, YY, and YN) independently diagnosed and evaluated 
122 cases. The histologic features of representative cases are 
shown in Figures 1 to 5. According to the 2011 IASLC clas-
sification, the specimens in Figures 1 and 2 were diagnosed 
as lepidic-pattern predominant and acinar-pattern predomi-
nant, respectively, by all eight pathologists. The specimen in 
Figure 3 was diagnosed as papillary-pattern predominant by 
three of the eight pathologists. The specimens in Figures 4 and 
5 were diagnosed as solid-pattern predominant and micropap-
illary-pattern predominant, respectively, by all eight patholo-
gists. The pathologists independently evaluated 21, 27, 36, 9, 
28, 22, 22, and 18 of the 122 cases as type A and B on the 
basis of the Noguchi’s classification. No cases were diagnosed 
as invasive mucinous carcinoma or colloid-predominant 
carcinoma.
According to Noguchi’s classification, the specimen in 
Figure 1 was diagnosed as type B by four of the pathologists, 
and those in Figures 2 through 5 were diagnosed as type E, 
type C, type D, and type F, respectively, by all the eight pathol-
ogists. In terms of nuclear grading, the specimen in Figure 1 
was diagnosed as negative by all the pathologists, and those in 
Figures 2 through 5 were diagnosed as positive by all the eight 
pathologists.
Figure 6 shows the distributions of the subtypes diag-
nosed by the pathologists, using the 2011 IASLC classification 
(Fig. 6A), Noguchi’s classification (Fig. 6B), nuclear grading 
(Fig. 6C), and the extent of the lepidic pattern in the largest 
cut surface (>75% or <75%)(Fig. 6D). In terms of the 2011 
IASLC classification (Fig. 6A), the pathologists diagnosed an 
average of 62.7 cases (±16.6 SD) as lepidic-pattern predomi-
nant, 25.8 cases (±12.7 SD) as acinar-pattern predominant, 
18.1 cases (±13.6 SD) as papillary-pattern predominant, 10.4 
cases (±2.0 SD) as solid-pattern predominant, and 5.1 cases 
(±2.3 SD) as micropapillary-pattern predominant. The dif-
ferences (SD) in the cases diagnosed as lepidic-pattern pre-
dominant, acinar-pattern predominant, and papillary-pattern 
predominant were significantly higher than those that were 
solid-pattern predominant and micropapillary-pattern pre-
dominant (F test, <0.05). In terms of Noguchi’s classification 
(Fig. 6B), the eight pathologists diagnosed an average of 5.1 
cases (±3.4 SD) as type A, 17.8 cases (±6.4 SD) as type B, 
70.6 cases (±11.0 SD) as type C, 10.6 cases (±3.0 SD) as type 
D, 9.5 cases (±3.5 SD) as type E, and 8.4 cases (±6.7 SD) as 
type F. In terms of nuclear grading (Fig 6C), the pathologists 
diagnosed an average of 47.0 cases (±10.3 SD) as negative 
and 75.0 cases (±10.3 SD) as positive; in terms of the extent of 
the lepidic pattern (>75% or <75%) (Fig 6D), they diagnosed 
an average of 34.6 cases (±17.3 SD) as showing more than 
75% lepidic growth and 87.4 cases (±17.3 SD) as showing 
less than 75% of lepidic growth.
TABLE 1.  Patient Characteristics
Characteristics No. of Patients
Number of patients 122
Sex (male / female) 64 / 58
Mean ± SD age (range) 61.5 yr ±10.4 (30–82 yr)
Mean ± SD tumor size (range) 15.2 mm ± 3.3(0.8–20 mm)
Tumor classification
 T1a 105
 T2a 10
 T3 6
 T4 1
Lymph node status
 N0 85
 N1 6
 N2 16
 N3 0
 Nx 15
Pleural invasion
 PL0 106
 PL1 11
 PL2 5
 PL3 0
Stage
 I (IA / IB) 97 (93 / 4)
 II (IIA / IIB) 7 (5 / 2)
 III (IIIA / IIIB) 18(17 / 1)
 IV 0
Type of resection
 Lobectomy 103
 Segmentectomy 5
 Wedge resection 14
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Interobserver agreement (κ value) of the histologic 
grading scheme for small pulmonary adenocarcinomas was 
then assessed. The pathologists evaluated the histologic 
grade independently, using the 2011 IASLC classification 
(Fig. 7A and B), Noguchi’s classification (Fig. 7C), nuclear 
grading (Fig. 7D), and the extent of the lepidic pattern (Fig. 7E). 
The mean (±SD) value of the κ statistic for the 2011 IASLC 
classification was 0.46 ± 0.09 (range, 0.24–0.61) (Fig7A). If 
we modified the classification into low grade (lepidic, aci-
nar, and papillary) and high grade (solid and micropapillary), 
the mean (±SD) value rose to 0.66 ± 0.09 (range,0.47–0.85). 
However, the mean (±SD) value for Noguchi’s classification 
and the extent of the lepidic pattern were 0.48 ± 0.09 (range, 
0.33–0.62) and 0.45 ± 0.16 (range, 0.14–0.70), respectively. 
The mean (±SD) value for nuclear grading was 0.58 ± 0.09 
(range, 0.43–0.73).
Prognostic Significance
The 5-year disease-free survival rates for the cases 
diagnosed according to the 2011 IASLC classification as 
lepidic-pattern predominant, acinar-pattern predominant, 
papillary-pattern predominant, solid-pattern predominant, 
FIGURE 2.  Histology of a small pulmonary adenocarcinoma 
judged to be acinar-pattern predominant on the basis of the 
international multidisciplinary classification (8 of 8 patholo-
gists), type E by Noguchi’s classification (8 of 8 pathologists), 
and positive by the nuclear grading system (8 of 8 patholo-
gists). Hematoxylin and eosin stain, original magnifications 
×200 and ×40.
FIGURE 3.  Histology of a small pulmonary adenocarcinoma 
judged to be papillary-pattern predominant on the basis of the 
international multidisciplinary classification (3 of 8 aptholo-
gists), type C by Noguchi’s classification (8 of 8 pathologists), 
and positive by the nuclear grading system (8 of 8 patholo-
gists). Hematoxylin and eosin stain, original magnifications 
×400 and ×40.
FIGURE 4.  Histology of a small pulmonary adenocarcinoma 
judged to be solid-pattern predominant on the basis of the 
international multidisciplinary classification (8 of 8 patholo-
gists), type D by Noguchi’s classification (8 of 8 pathologists), 
and positive by the nuclear grading system (8 of 8 patholo-
gists). Hematoxylin and eosin stain, original magnifications 
×400 and ×40.
FIGURE 5.  Histology of a small pulmonary adenocarci-
noma judged to be micropapillary-pattern predominant on 
the basis of the international multidisciplinary classification 
(6 of 8 pathologists), type F by Noguchi’s classification (8 of 
8 pathologists) and positive by the nuclear grading system 
(8 of 8 pathologists). Hematoxylin and eosin stain, original 
magnifications ×400 and ×40.
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and micropapillary-pattern predominant were 91.4% (±4.2 
SD) (range, 84–97), 75.4% (±7.4 SD) (range, 65–87), 59.1% 
(±7.7 SD) (range, 48–67), 44.5% (±4.7 SD) (range, 39–51), 
and 33.1% (±22.2 SD) (range, 0–58), respectively. For cases 
diagnosed using Noguchi’s classification as types A, B, C, D, 
E, and F the corresponding rates were 100%, 100%, 79.6% 
(±3.8 SD) (range, 72–84), 42.5% (±4.9 SD) (range, 33–50), 
72.9% (±7.9 SD) (range, 60–86), and 50.6% (±15.6 SD) 
(range, 33–76), respectively.
The 5-year disease-free survival rates for the cases 
diagnosed as positive and negative using nuclear grading 
were 68.6% (±3.1 SD) (range, 63.2–72.3) and 91.8% (±2.7 
SD) (range, 87.8–95.5), respectively (Table 2). The intergroup 
difference in the survival rates was statistically significant (p < 
0.05). Similarly, for cases diagnosed according to the extent of 
the lepidic growth component (>75% or <75%) and modified 
2011 IASLC classification (low grade and high grade) (Table 
2), the 5-year disease-free survival rates were 97.0% (±3.6 SD) 
(range, 90.5–100)/70.3% (±4.1 SD) (range, 64.3–75.8) and 
80.6%(±0.6 SD)(range, 79.8–81.5)/44.5%(±4.5 SD)(range, 
37.5–51.0), respectively. This difference was also statistically 
significant (p < 0.05).
DISCUSSION
Figures 1 to 5 show representative cases for which 
the rates of interobserver agreement were relatively high. 
According to the 2011 IASLC classification, the specimen 
in Figure 1 was diagnosed as lepidic-pattern predominant by 
all eight pathologists (100% agreement), whereas in terms of 
Noguchi’s classification, it was diagnosed as type B by four of 
the eight pathologists (50% agreement). Conversely, the spec-
imen in Figure 3 was diagnosed as papillary-pattern predomi-
nant by three of the eight pathologists (37.5% agreement), and 
diagnosed as type C by all the eight pathologists (100% agree-
ment). However, the specimens in Figures 2 and 4 were diag-
nosed as acinar- and solid-pattern predominant, and as types E 
and D by all the eight pathologists (100% agreement for both 
classifications). These results for the interobserver agreements 
obtained, using the two histological classifications, showed 
differences in the standards by which histological features 
were judged.
Figure 6A shows that the mean rate (±SD) of diagno-
sis as lepidic-pattern predominant, among the eight patholo-
gists, was 62.7% (±16.6 SD). The standard deviation was 
highest among all the types. We suspected that the diag-
nostic criteria for a lepidic pattern differed considerably 
among the pathologists. Figure 6B shows that the mean rate 
(±SD) of type C, among the eight pathologists, was 70.6% 
(±11.0 SD), the standard deviation being highest among 
all the types of Noguchi’s classification. Therefore, similar 
to the diagnostic criteria for a lepidic pattern in the 2011 
IASLC classification, the criteria for type C in Noguchi’s 
FIGURE 6.  Number of diagnostic subtypes among pathologists for (A), the modified World Health Organization classification; 
(B), Noguchi’s classification; (C), nuclear grading; and (D), the extent of the lepidic area (cutoff value 75%).
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classification are also thought to differ considerably among 
pathologists.
However, Figure 6C shows that the mean rate (±SD) of 
cases judged as negative and positive cases, among the eight 
pathologists, was 47.0% (±10.3 SD) and 75.0% (±10.3 SD), 
respectively, because the standard deviation for nuclear grad-
ing is lower than that for the 2011 IASLC classification or 
Noguchi’s classification. Therefore, the nuclear grading sys-
tem is thought to be better for practical use.
The average (±SD) κ values for the 2011 IASLC clas-
sification (Fig 7A), Noguchi’s classification (Fig 7C), and the 
extent of the lepidic area (Fig7E) were 0.46 ± 0.09, 0.48 ± 0.09, 
and 0.45 ± 0.16, respectively. All of them showed moderate 
agreements. However, when we modified the 2011 IASLC 
classification into low grade (lepidic, acinar, and papillary) 
and high grade (solid and micropapillary), the value rose to 
0.66 ± 0.09 (range, 0.47–0.85). The mean (±SD) κ value for 
nuclear grading (Fig 7D) was 0.58 ± 0.09. The mean (±SD) 
value of the κ statistic for interobserver agreement on nuclear 
grading was relatively high among the histological parameters 
examined in this study and was considered suitable for practi-
cal use together with modified 2011 IASLC classification.
FIGURE 7.  Comparison of subdiagnostic results obtained by eight pathologists for (A), 2011 IASLC classification; (B), Modified 
2011 IASLC classification, two-category, low grade; acinar pattern/papillary pattern/lepidic pattern, high grade; solid pattern/
micropapillary pattern; (C), Noguchi’s classification; (D), nuclear grading; and (E) the extent of the lepidic area (cutoff value 
75%). IASLC, International Association for the Study of Lung Cancer.
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However, the prognostic significance (5-year disease-
free survival rate) of low-grade histology as defined by the 
modified IASLC classification, types A and B of Noguchi’s 
classification, cases with a negative nuclear grading, and 
cases showing a lepidic-predominant area more than 75% was 
80.6% (±0.6 SD), 100%, 91.8% (±2.7 SD), and 97.0% (±3.6 
SD), respectively. The average numbers of cases classified as 
having low-grade histology by the modified 2011 IASLC clas-
sification, types A and B of Noguchi’s classification, a nega-
tive nuclear grading, and a lepidic-predominant area of more 
than 75% were 106.5 (±1.9 SD), 22.9 (±7.9 SD), 75.0 (±10.3 
SD), and 34.6 (±17.3 SD), respectively. These results indicate 
that the above four factors are promising prognostic indicators 
that facilitate selection of patients as suitable candidates for 
limited surgery. In this study, adenocarcinaom in situ (AIS) 
and minimally invasive adenocarcinoma (MIA) are included 
because we wanted to examine interobserver viability of all 
histological subtypes, including AIS and MIA. Therefore, the 
survival rate of the lepidic-predominant adenocarcinoma may 
be influenced by them.
Among these factors, only nuclear grade has the pos-
sibility of being applied in preoperative biopsy and cytology 
diagnoses. However, the information from these materials 
is limited and the judgment should be carefully examined. 
In the future, the usefulness of nuclear grading as a preop-
erative prognostic factor of small adenocarcinomas should 
be examined further, using more biopsy and cytology mate-
rials. By the other nuclear criteria, preliminary data suggest 
poor prognosis may be associated with nuclear grading,9,14 
mitoses,15,16 and cytology grading system.17,18
In conclusion, we examined the interobserver reproduc-
ibility of four prognostic factors for small primary adenocar-
cinomas (≤2cm) of the lung, according to the 2011 IASLC 
classification, Noguchi’s classification, nuclear grading, and 
the extent of the lepidic-predominant area (≥75%), and veri-
fied that nuclear grading is the most reliable and promising of 
these with high reproducibility. We have thus demonstrated 
that the nuclear grading system has a high rate of agreement 
and is useful for prognostication.
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